Adhera Therapeutics Inc (ATRX)

[sc00pnDump]

Is Melior Pharmaceuticals still working with Adhera Therapeutics as far as licensing is concerned from 2 years prior?

Have a good day

[mrinvestor08]

Management team very quiet after eliminating $7.8M in debt....

[EOT]

Good opportunity to buy, but maybe they take it into the 1’s??….. I definitely don’t think it’s left over dilution, but MM’s trying to load this TINY float.

Regardless news has to hit anytime so owning shares is smart!!!!! Imo

[sc00pnDump]

Good morning everyone,
Have a great day.

[mrinvestor08]

I have probably spent days studying this stock. All filings I've read them all even on the bdrx side :)

[sc00pnDump]

Just wondering if you have been reading their last entries forms 424b3 from December 26 bdrx sec filings, Adhera is
Mentioned.

If it’s been done please disregard

Have a great night

[sc00pnDump]

;)

[mrinvestor08]

If otcn is on the ask again tomorrow I guess a few of us will continue to add here ;)

[mrinvestor08]

Nice to see those blue bars at least. Let's see got some high and low today.

[EOT]

That was a mm accumulation move

[wedman]

Not hard to bring it down - tiny ss - can move quick in either direction -

[mrinvestor08]

Debt remains here for sure....something going on. Hopefully anything left a deal is made they get shares and we move on. Let's see.

Still believe this is the golden ticket!

[EOT]

Looks like MM’s bring it down like that to load shares?

Cleaning out the 2’s

[mrinvestor08]

What debt remains here hmmmm

[sc00pnDump]

Looking good

[sc00pnDump]

That’s not much selling, someone bought a chunk at 01 and dumped at 02 +, some profit, however this float is tiny. Talk about fuel and once you see more mm coming over , then watch out, my only concern is their AS, hoping they don’t start dumping.

Otherwise I will start buying up the float

Have a good day ahead

[mrinvestor08]

Desperate sellers here...they just don't see it.

Otcn on bid and ask

[EOT]

Definitely a rare find….

Your back, I guess your deep dive convinced you then.

[sc00pnDump]

Good morning all, hoping you had a great holiday, I bought a small position
Will increase more as the week progresses
(Whales have been notified!!)

Have a great day

[EOT]

Someone Needed the dough$
Now watch news hit… that would hurt.

[mrinvestor08]

Why dump this 8 million in debt gone...

[EOT]

Someone needs money…..

[mrinvestor08]

Nice buys

[EOT]

ATRX….who’s here now are ground floor investors!

Major Update on operations is imminent…..

[EOT]

ATRX……waiting patiently….

[mrinvestor08]

Jan 2 share update...Same share structure as dec 21...beauty. will add more by Friday.

[mrinvestor08]

When it runs the board will be pumped but a few crybabies will come back here and complain. Too bad so sad is all I gotta say!

[mrinvestor08]

No brainer here!

[EOT]

When you read their plans it shouldn’t be so cheap much longer? One major deal already done….
Update imminent, then it all changes…. Debt free!

[mrinvestor08]

Whoever is sitting at 0.025...another 250 bucks and u get 3s. Not a big deal I added a bunch of 3s more than a week ago.

[mrinvestor08]

Let's close at 0.04 ;)

[mrinvestor08]

The calm before storm $

[EOT]

News will come. It has to, they just executed a MAJOR move! And when it does, imo it should be impressive…. Waiting!

[mrinvestor08]

Looks like cavalry fund aka past noteholder now owns 10% of BDRX:

https://www.otcmarkets.com/filing/html?id=17149222&guid=7ZJ-kKVtZchRB3h

[wedman]

They will when news hit -

[mrinvestor08]

Bid sitting gets you nowhere with this stock. Smack that ask.

[EOT]

Well they have to update soon, and I’m waiting!

Have a Great Christmas's……

[mrinvestor08]

Update 8k and an adjusted s1 filing would be perfect :)

[EOT]

They have this drug relicensed for Parkinson’s.
It’s kind of like how viagra was created for one thing, but discovered it treats dementia as example.

This will be huge imo…..

“MLR-1019 (armesocarb) is a new class of drug for Parkinson's Disease (PD) and represents the only drug to address both movement and non-movement symptoms of PD. Armesocarb is the active enantiomer in mesocarb, a drug marketed in Europe for 37 years for various psychiatric and central nervous system indications.“

[EOT]

Imo the small increase was likely part of eliminating the entire VC debt? They can’t dilute because nobody holds debt/shares against Atrx anymore.

She’s a clean as a whistle…..

Watching for an 8k and PR at anytime now

[mrinvestor08]

Hmmm 1.5 million increase. Now that the deal is closed I am hoping any further additions to the share count are limited.

[wedman]

Nice that it was updated yesterday! Still good !

[EOT]

Outstanding Shares
8,720,090
12/21/2023


Getting ready for the news!!

[mrinvestor08]

Hmmm in a rush to get this deal done and they did it way before March.

Wondering what the hurry was...🤔

Something huge coming here IMO

[EOT]

Nice. Maybe now we get a major update?
And it will be good imo!!!

This company works fast. They said one month and it’s only been 3weeks to close a major deal!

[mrinvestor08]

BDRX filing today, offering closed. ATRX noteholders gone! ATRX given $640,000 cash. Anybody know how much it costs to uplist to nasdaq? ;)

https://www.otcmarkets.com/filing/html?id=17136702&guid=QVJ-keketgNAB3h

Acquisition of Tolimidone License



As disclosed in the Company’s Report on Form 6-K filed with the Commission on November 27, 2023 (the “November 27 6-K”), the Company entered into a series of agreements with (a) Adhera Therapeutics, Inc. (“Adhera”) and certain of its secured noteholders (the “Secured Noteholders”), including an Assignment and Exchange Agreement dated November 22, 2023 (the “Assignment and Exchange Agreement”), a Lock-Up Agreement and a Registration Rights Agreement, and (b) Melior Pharmaceuticals I, Inc. (“Melior”), including a License Agreement dated November 22, 2023 (the “License Agreement”), a Lock-Up Agreement and a Registration Rights Agreement. The description of the foregoing agreements is incorporated herein by reference to the November 27 6-K.



On December 21, 2023, the Company completed the closing of the transactions contemplated by each of the Assignment and Exchange Agreement and the License Agreement (the “Closings”). As a result of the Closings, (i) Adhera agreed to assign all of its rights to the compound tolimidone, a selective activator of the enzyme lyn kinase which increase phosphorylation of insulin substrate -1, to the Company and (ii) the Company acquired from Melior an exclusive, worldwide, sublicensable right to develop, manufacture, commercialize, or otherwise exploit products containing tolimidone for any field. As consideration, the Company (i) as an upfront payment under the Assignment and Exchange Agreement, paid $640,000 to Adhera and issued (x) an aggregate of 224,947 Depositary Shares to certain Noteholders and (y) an aggregate of 2,275,050 pre-funded warrants to purchase Depositary Shares to certain of the Noteholders (collectively, the “Noteholder Securities”) and (ii) issued to Melior 354,428 of its Depositary Shares (the “Melior Shares”). Subject to satisfaction of certain obligations under the License Agreement, the Company further expects to issue 354,428 of its Depositary Shares to Bukwang Pharmaceuticals Co., Ltd. (collectively with the Melior Shares, the “License Shares”).

[backtoreality]

Shhhh.

Funds don't clear till tomorrow morning.

[mrinvestor08]

Float only 4.4 million shares.

7.8 million debt GONE.

Getting cash in this deal and future royalties. S1 still in play from last year. Is an upgrade to nasdaq coming?

All the stars are aligning here!

[EOT]

Post #3480

[sc00pnDump]

Thankyou, I will do some more research.
If it looks good, I will jump on it.

Have a great holiday all.